Class IITerminatedD-0652-2016
Drug recall · February 10, 2016
Nystatin recall
Why: Labeling: label error on declared strength.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Nystatin, USP Powder for Rx compounding, 150 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDC 0574-0404-15, UPC 305740404157
- Lots / codes
Lot #: 2015080484, Exp 02/2016
- Quantity
- 918 units
- Company
- Perrigo Company PLC, Allegan, MI
- Distribution
- Nationwide
- Initiated
- January 18, 2016 · Voluntary: Firm initiated
- Classified
- February 4, 2016
- Reported
- February 10, 2016
- Ended
- June 20, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nystatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.